Journal ArticleOPEN ACCESS

PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma

  • Lee Y
  • Sunwoo J
Journal for ImmunoTherapy of Cancer (2014) 2(Suppl 3) P270
DOI: 10.1186/2051-1426-2-s3-p270
N/ACitations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Meeting abstracts Human tumors consist of heterogeneous populations with different phenotypic characteristics, and these subpopulations can often be distinguished by different surface marker expression. In head and neck squamous cell carcinoma (HNSCC), CD44 has been identified to be a marker of a

Cite

CITATION STYLE

APA

Lee, Y., & Sunwoo, J. (2014). PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer, 2(Suppl 3), P270. https://doi.org/10.1186/2051-1426-2-s3-p270

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free